Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,708 | 89,789 | 185,636 | 241,148 | 340,522 |
| Marketable Securities | 67,107 | 7,907 | 499 | 27,091 | 20,385 |
| Receivables | 21,469 | 15,268 | 29,629 | 15,874 | 12,099 |
| Inventories | N/A | N/A | N/A | 1,606 | 2,897 |
| Other current assets | 7,721 | 30,847 | 9,665 | 29,643 | 15,617 |
| TOTAL | $233,005 | $143,811 | $225,429 | $315,362 | $391,520 |
| Non-Current Assets | |||||
| PPE Net | 54,681 | 63,621 | 78,846 | 71,673 | 23,712 |
| Intangibles | 671 | 718 | 1,854 | 1,584 | 1,108 |
| Other Non-Current Assets | 45,913 | 53,066 | 75,947 | 80,852 | 51,129 |
| TOTAL | $101,265 | $117,405 | $156,647 | $154,109 | $75,949 |
| Total Assets | $334,270 | $261,216 | $382,076 | $469,471 | $467,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,289 | 5,088 | 2,354 | N/A | N/A |
| Accounts payable and accrued liabilities | 19,069 | 21,456 | 23,762 | 24,609 | 29,264 |
| Other current liabilities | 11,959 | 13,656 | 14,602 | 20,258 | 12,240 |
| TOTAL | $155,144 | $62,995 | $49,348 | $52,015 | $62,604 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,125 | 20,531 | 20,030 | 28,836 | N/A |
| Deferred Revenues | 110,325 | 59 | 301 | 452 | 20,033 |
| aiOther Non-Current Liabilities | 52,532 | 59,642 | 87,135 | 96,183 | 62,516 |
| TOTAL | $94,431 | $72,279 | $96,255 | $108,610 | $49,395 |
| Total Liabilities | $249,575 | $135,275 | $145,602 | $160,625 | $111,999 |
| Shareholders' Equity | |||||
| Common Shares | 4,365 | 2,955 | 2,945 | 2,785 | 2,767 |
| Retained earnings | -405,766 | -439,504 | -698,326 | -587,035 | -508,481 |
| Other shareholders' equity | -36,689 | -20,632 | -2,841 | 20,962 | 17,706 |
| TOTAL | $84,695 | $125,941 | $236,474 | $308,846 | $355,470 |
| Total Liabilities And Equity | $334,270 | $261,216 | $382,076 | $469,471 | $467,469 |